Spiegel Robert J.
Transaction: 06/30/2026
BUY
Change
+6,103
Price
$1.28
Filing
07/01/2026
Type
BUY
Geron Corporation
GERN • Biotechnology
$1.57
▲ +0.06 (+3.97%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.05B
Growth
-4.4%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 183.8%Healthy liquidity · 4.66Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.57
Change3.97%
Shares Out670.70M
Market Cap$1.05B
Enterprise Value$872.27M
52W Range1.04 - 2.01
Beta0.60
P/E-15.07
P/S5.15
P/B4.82
P/FCF-5.92
EV/Sales4.26
Price$1.57
Change3.97%
Shares Out670.70M
Market Cap$1.05B
Enterprise Value$872.27M
52W Range1.04 - 2.01
Beta0.60
P/E-15.07
P/S5.15
P/B4.82
P/FCF-5.92
EV/Sales4.26
EV/EBITDA-19.11
EV/FCF-4.90
Earnings Yield-6.64%
FCF Yield-16.90%
Dividend Yield0.00%
Gross Margin97.42%
Oper. Margin-29.28%
Profit Margin-46.65%
Debt/Eq1.11
Current Ratio4.66
Quick Ratio4.66
Revenue 5Y-4.44%
Target$5.89
Target Upside275.16%
Target Median$6.00
Target Range4.00 - 8.00
Volume15.95M
Avg Volume12.69M
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
50
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
68/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
67/100
Why this score▼
Positive revenue growth · 183.8%Healthy liquidity · 4.66Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
84/100
Bullish
Bullish
15
Hold
7
Bearish
0
Price Target
2026-08-07
Low
$4.00
Mean
$5.89
Median
$6.00
High
$8.00
Insider Transactions
Recent executive and insider activity
Bir Dawn Carter
Transaction: 05/20/2026
BUY
Change
+220,000
Price
$1.26
Filing
05/26/2026
Type
BUY
McDonald John F
Transaction: 05/20/2026
BUY
Change
+220,000
Price
$1.26
Filing
05/26/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Spiegel Robert J. | BUY | +6,103 | $1.28 | 06/30/2026 | 07/01/2026 |
| Bir Dawn Carter | BUY | +220,000 | $1.26 | 05/20/2026 | 05/26/2026 |
| McDonald John F | BUY | +220,000 | $1.26 | 05/20/2026 | 05/26/2026 |
| Molineaux Susan | BUY | +220,000 | $1.26 | 05/20/2026 | 05/26/2026 |
| O'Farrell Elizabeth G. | BUY | +220,000 | $1.26 | 05/20/2026 | 05/26/2026 |
| Spiegel Robert J. | BUY | +220,000 | $1.26 | 05/20/2026 | 05/26/2026 |
| Williams Timothy | OTHER | 0 | Not reported | 04/13/2026 | 04/14/2026 |
| Williams Timothy | BUY | +2,500,000 | $1.73 | 04/13/2026 | 04/14/2026 |
| Spiegel Robert J. | BUY | +5,243 | $1.49 | 03/31/2026 | 04/01/2026 |
| Andrews Patricia S | OTHER | 0 | Not reported | 03/25/2026 | 03/26/2026 |
| Andrews Patricia S | BUY | +270,000 | $1.57 | 03/25/2026 | 03/26/2026 |
| Chinoporos Constantine | OTHER | 0 | Not reported | 03/25/2026 | 03/26/2026 |
| Chinoporos Constantine | BUY | +270,000 | $1.57 | 03/25/2026 | 03/26/2026 |
| ROBERTSON MICHELLE | SELL | -9,855 | $1.94 | 02/18/2026 | 02/19/2026 |
| ROBERTSON MICHELLE | SELL | -27,500 | Not reported | 02/18/2026 | 02/19/2026 |
| ROBERTSON MICHELLE | BUY | +1,660,000 | $1.80 | 02/17/2026 | 02/19/2026 |
| Eid Joseph | BUY | +2,220,000 | $1.80 | 02/17/2026 | 02/19/2026 |
| Spiegel Robert J. | BUY | +5,918 | $1.32 | 12/31/2025 | 01/05/2026 |
| ElNawawi Ahmed | OTHER | 0 | Not reported | 10/20/2025 | 10/20/2025 |
| ElNawawi Ahmed | BUY | +3,000,000 | $1.27 | 10/20/2025 | 10/20/2025 |